Alzheimer's Disease (AD)
13
6
8
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 13 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (13)
Impact of Ketoflex 12/3 Diet on Early-to-Mid Stage Alzheimer's Progression
Development of Measures to Screen for Financial Hardship in Alzheimer's Disease and Dementia
Cognitive Health in Ageing Register: Investigational and Observational Trial Studies in Dementia Research (CHARIOT): Prospective Readiness Cohort (PRO) Longitudinal Study
Cervical Lymphatico-Venous Bypass for Treatment of Alzheimer's Disease - Proof of Concept Study (CLyVeB-AD-1 Study)
Improving Executive Control in Cognitively Healthy Older Adults: the MUltitasking STrategy (MUST) Study
VY7523-102: Randomized, Placebo-Controlled, Double-Blind, Multiple Ascending Dose Study in Participants With Early Alzheimer's Disease
Effects of Transcranial Ultrasound Stimulation (TUS) on Neurological and Cognitive Outcomes in Neurodegenerative Diseases
Using SRT to Improve The Drinking Problem Behavior of Elderly People With Dementia During The Care of Day Care
Radiolabeled TSPO Targeted Molecular Probe in Alzheimer's Disease.
VR-based Physical Activity and Reminiscence Therapy
Multimodal Ophthalmic Imaging and Plasma Biomarkers for the Early Detection of Alzheimer's Disease
Association Between Age-related Macular Degeneration and Cognitive Impairment Based on Exosome Proteomics
Biomarkers in a Candian Memory Clinic